Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart.
Mack CA, Patel SR, Schwarz EA, Zanzonico P, Hahn RT, Ilercil A, Devereux RB, Goldsmith SJ, Christian TF, Sanborn TA, Kovesdi I, Hackett N, Isom OW, Crystal RG, Rosengart TK. Mack CA, et al. Among authors: isom ow. J Thorac Cardiovasc Surg. 1998 Jan;115(1):168-76; discussion 176-7. doi: 10.1016/s0022-5223(98)70455-6. J Thorac Cardiovasc Surg. 1998. PMID: 9451061 Free PMC article.
Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion.
Mack CA, Magovern CJ, Budenbender KT, Patel SR, Schwarz EA, Zanzonico P, Ferris B, Sanborn T, Isom P, Ferris B, Sanborn T, Isom OW, Crystal RG, Rosengart TK. Mack CA, et al. Among authors: isom ow, isom p. J Vasc Surg. 1998 Apr;27(4):699-709. doi: 10.1016/s0741-5214(98)70236-8. J Vasc Surg. 1998. PMID: 9576084 Free article.
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.
Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG. Rosengart TK, et al. Among authors: isom ow. Circulation. 1999 Aug 3;100(5):468-74. doi: 10.1161/01.cir.100.5.468. Circulation. 1999. PMID: 10430759 Clinical Trial.
Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.
Rosengart TK, Lee LY, Patel SR, Kligfield PD, Okin PM, Hackett NR, Isom OW, Crystal RG. Rosengart TK, et al. Among authors: isom ow. Ann Surg. 1999 Oct;230(4):466-70; discussion 470-2. doi: 10.1097/00000658-199910000-00002. Ann Surg. 1999. PMID: 10522716 Free PMC article. Clinical Trial.
154 results